|
|
|
December marks the 19th anniversary of UroToday - GU Oncology Today, Digital Science Press LLC. We want to extend our warmest gratitude to our readers and site users, our partners and collaborators, our patients and survivors, and the global healthcare community who continue to inspire and support us in our mission to elevate access to practice informing care and bridge the gap between patients and clinicians. We remain steadfast in our dedicated to providing clinically relevant education that clinicians need to stay at the forefront of the dynamic field of genitourinary treatments and empowering patients with the knowledge to take control of their healthcare journey.
|
|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS |
|
|
|
|
|
|
Tumor Board Reviewing the Use of PSMA PET in Patient with Gleason 4+5=9, GG 5 Disease, Bone Scan Demonstrated Mild Uptake Prostate Cancer
|
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 72-year-old male with no past medical history is presented. He has been followed for some time at this point. His PSA in December 2021 was 8.44. His repeat PSA in Feb 2022 was 7.61 and his DRE was notable for having a left-sided firm nodule. His prostate biopsy in March of 2022, was notable for Gleason 4+5=9 prostate adenocarcinoma. |
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in the Care of Patient with Gleason 4+5=9, GG 5 with Seminal Vesicle Invasion Prostate Cancer |
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 57 year old man with a history of coronary artery disease and Barrett's esophagus. is presented, evaluated, and his treatment plan addressed. |
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in the Care of Patient Who Underwent Fluciclovine for Prostate Cancer |
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer, a case of a 64 year old man with a history of kidney stones presented, evaluated, and his treatment plan addressed. |
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in Prostate Cancer - Gleason 4+4=8 GG 4, 12 of 12 Cores, High Risk Localized Disease |
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer evaluates a case of a 62-year-old man with a history of hypertension. |
|
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in Prostate Cancer - Gleason 3+3=6 GG 1, PALB2 Mutation |
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer evaluates a case of a 63-year-old man with no significant past medical history. |
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
